Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer.

Atalay G., Cardoso F., Awada A., Piccart M.

Annals of oncology : official journal of the European Society for Medical Oncology, vol.14, pp.1346-63, 2003 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14
  • Publication Date: 2003
  • Doi Number: 10.1093/annonc/mdg365
  • Journal Name: Annals of oncology : official journal of the European Society for Medical Oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1346-63
  • Keywords: Akt, breast cancer, EGFR (ErbB) family, HER-2, MAPK, TYROSINE KINASE INHIBITOR, ESTROGEN-RECEPTOR, ZD1839 IRESSA, MONOCLONAL-ANTIBODY, PHASE-II, PROGNOSTIC VALUE, CROSS-TALK, HER2 OVEREXPRESSION, SIGNAL-TRANSDUCTION, BISPECIFIC ANTIBODY
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No